Optimization of Chitosan Succinate and Chitosan Phthalate Microspheres for Oral Delivery of Insulin using Response Surface Methodology

In the present study, a Box-Behnken experimental design was employed to statistically optimize the formulation parameters of chitosan phthalate and chitosan succinate microspheres preparation. These microspheres can be useful for oral insulin delivery system. The effects of three parameters namely polymer concentration, stirring speed and cross linking agent were studied. The fitted mathematical model allowed us to plot response surfaces curves and to determine optimal preparation conditions. Results clearly indicated that the crosslinking agent was the main factor influencing the insulin loading and releasing. The in vitro results indicated that chitosan succinate microspheres need high amount of crosslinking agent to control initial burst release compared to chitosan phthalate microspheres. The reason may be attributed that chitosan succinate is more hydrophilic than chitosan phthalate. The relative pharmacological efficacy for chitosan phthalate and chitosan succinate microspheres (18.66 ± 3.84%, 16.24 ± 4%) was almost three-fold higher than the efficacy of the oral insulin administration (4.68 ± 1.52%). These findings suggest that these microspheres are promising carrier for oral insulin delivery system.

[1]  Hui Xu,et al.  Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres. , 2002, Acta pharmacologica Sinica.

[2]  H E Junginger,et al.  Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  Y. Sultana,et al.  Chitosan Phthalate Microspheres for Oral Delivery of Insulin: Preparation, Characterization, and In Vitro Evaluation , 2007, Drug delivery.

[4]  A. Jayakrishnan,et al.  Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. , 1994, Journal of biomaterials science. Polymer edition.

[5]  Akira Yamamoto,et al.  Penetration and enzymatic barriers to peptide and protein absorption , 1989 .

[6]  R. Khar,et al.  Development and characterization of chitosan succinate microspheres for the improved oral bioavailability of insulin. , 2007, Journal of pharmaceutical sciences.

[7]  H. Junginger,et al.  Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo. , 2001, Journal of pharmaceutical sciences.

[8]  J. Hastewell,et al.  Peptide drug delivery: Colonic and rectal absorption , 1997 .

[9]  M. Taha,et al.  Synthesis of Chitosan Succinate and Chitosan Phthalate and Their Evaluation as Suggested Matrices in Orally Administered, Colon‐Specific Drug Delivery Systems , 1999, Archiv der Pharmazie.

[10]  N. Peppas,et al.  Mechanisms of solute release from porous hydrophilic polymers , 1983 .

[11]  N. Peppas,et al.  Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[12]  H. Junginger,et al.  CHITOSAN AND CHITOSAN DERIVATIVES AS ABSORPTION ENHANCERS FOR PEPTIDE DRUGS ACROSS MUCOSAL EPITHELIA , 1999 .

[13]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[14]  J. Madara Intestinal absorptive cell tight junctions are linked to cytoskeleton. , 1987, The American journal of physiology.

[15]  P. Costa,et al.  Modeling and comparison of dissolution profiles. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  H. Junginger,et al.  Chitosan and its derivatives as intestinal absorption enhancers. , 2001, Advanced drug delivery reviews.

[17]  Hui Xu,et al.  Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. , 2002, International journal of pharmaceutics.

[18]  M. Chinnan,et al.  Controlling molecular weight and degree of deacetylation of chitosan by response surface methodology. , 2002, Journal of agricultural and food chemistry.